There are still some issues to solve prior to introducing liquid biopsy technology in routine clinical practice regarding preanalytical aspects and low-circulating tumor content, considering that common PC copy number variants, such as PTEN or CDH1 deletions, are undetectable in the presence of a low ctDNA fraction [68]. This evidence concerns the gene PTEN and neoplasm.